RXO, Inc.
RXO
$15.76
$0.070.45%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.74B | 5.94B | 5.56B | 5.07B | 4.55B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.74B | 5.94B | 5.56B | 5.07B | 4.55B |
| Cost of Revenue | 4.80B | 4.96B | 4.63B | 4.22B | 3.77B |
| Gross Profit | 941.00M | 982.00M | 928.00M | 854.00M | 783.00M |
| SG&A Expenses | 832.00M | 850.00M | 791.00M | 731.00M | 666.00M |
| Depreciation & Amortization | 116.00M | 121.00M | 116.00M | 103.00M | 87.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.75B | 5.93B | 5.54B | 5.05B | 4.52B |
| Operating Income | -7.00M | 11.00M | 21.00M | 20.00M | 30.00M |
| Income Before Tax | -115.00M | -97.00M | -324.00M | -322.00M | -304.00M |
| Income Tax Expenses | -15.00M | -18.00M | -16.00M | -16.00M | -14.00M |
| Earnings from Continuing Operations | -100.00 | -79.00 | -308.00 | -306.00 | -290.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -100.00M | -79.00M | -308.00M | -306.00M | -290.00M |
| EBIT | -7.00M | 11.00M | 21.00M | 20.00M | 30.00M |
| EBITDA | 109.00M | 132.00M | 137.00M | 123.00M | 117.00M |
| EPS Basic | -0.59 | -0.47 | -2.20 | -2.21 | -2.15 |
| Normalized Basic EPS | -0.17 | -0.11 | -0.06 | -0.06 | -0.04 |
| EPS Diluted | -0.59 | -0.47 | -2.20 | -2.21 | -2.15 |
| Normalized Diluted EPS | -0.17 | -0.11 | -0.06 | -0.06 | -0.04 |
| Average Basic Shares Outstanding | 673.84M | 669.53M | 635.05M | 584.10M | 533.30M |
| Average Diluted Shares Outstanding | 673.84M | 669.53M | 635.05M | 584.10M | 533.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |